Cargando…
Correlation of PD-L1 Expression of Tumor Cells with Survival Outcomes after Radical Intensity-Modulated Radiation Therapy for Non-Metastatic Nasopharyngeal Carcinoma
PURPOSE: We investigated if programmed death-ligand 1 (PD-L1) expression levels were prognostic of survival outcomes after intensity-modulated radiation therapy (IMRT) for non-metastatic nasopharyngeal carcinoma (NPC). METHODS AND MATERIALS: 104 patients with non-metastatic NPC treated with radical...
Autores principales: | Lee, Victor H. F., Lo, Anthony W. I., Leung, Chun-Yin, Shek, Wai-Hung, Kwong, Dora L. W., Lam, Ka-On, Tong, Chi-Chung, Sze, Chun-Kin, Leung, To-Wai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4920427/ https://www.ncbi.nlm.nih.gov/pubmed/27341634 http://dx.doi.org/10.1371/journal.pone.0157969 |
Ejemplares similares
-
Radiation recall after capecitabine in a patient with recurrent nasopharyngeal carcinoma: a case report
por: Lee, Victor, et al.
Publicado: (2016) -
Prognostication of Half-Life Clearance of Plasma EBV DNA in Previously Untreated Non-metastatic Nasopharyngeal Carcinoma Treated With Radical Intensity-Modulated Radiation Therapy
por: Chan, Sik-Kwan, et al.
Publicado: (2020) -
Prognostication of serial post-intensity-modulated radiation therapy undetectable plasma EBV DNA for nasopharyngeal carcinoma
por: Lee, Victor Ho-Fun, et al.
Publicado: (2016) -
Tuberculosis reactivation at ileum following immune checkpoint inhibition with pembrolizumab for metastatic nasopharyngeal carcinoma: a case report
por: Lau, Kin-Sang, et al.
Publicado: (2021) -
Bevacizumab-containing regimens after cetuximab failure in Kras wild-type metastatic colorectal carcinoma
por: LAM, KA ON, et al.
Publicado: (2013)